Also, GRh2 is considered a chemotherapeutic agent for leukemia therapy by inducing apoptosis through the mitochondrial pathway including mitochondrial depolarization, cytochrome complex release, and activation of caspase-9 and caspase-3 in acute leukemia cells.38 Here, CASP9 is linked to leukemia.